Novel events in the molecular regulation of muscle mass in critically ill patients
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Non‐technical summary A clinical trait of critically ill patients following trauma, surgical complications and/or sepsis is the presence of a marked skeletal muscle wasting, which severely compromises muscle function, especially the respiratory muscles, and clinical outcomes such as morbis, mortality and the length of hospitalization. However, the molecular mechanisms responsible for this are largely unresolved. In this paper we provide novel and interesting translational data that show how the muscle mass is regulated during critical illness. The present observations also show that the muscle signalling pathways are not only important for the size of muscle mass, but could also play a significant role in the whole body glucose control. This is extremely important and relevant to the clinical setting as uncontrolled blood glucose concentrations in critically ill patients impact on clinical outcome. From a clinical perspective, the present data suggest therapeutic strategies to preserve muscle mass and metabolic function in critical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 2×
“Two muscle-specific E3-ligases belonging to the ubiquitin–proteasome complex, muscle RING-finger 1 (MuRF1) and muscle atrophy F-box (MAFbx), have been identified as key-regulators of 26S proteasome-mediated protein breakdown in cell-based studies and animal models of muscle wasting (Bodine et al. 2001; Gomes et al. 20…”
BackgroundSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 2×
“Furthermore, the reduction of Akt phosphorylation in catabolic conditions is purported to be involved in the upregulation of muscle protein breakdown through activation of MAFbx and MuRF1 (Sandri et al. 2004).”
BackgroundRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819 · cited 2×
“This is thought to occur by myostatin-mediated inhibition of the myogenic regulators MyoD, myogenin and Myf5 (Lee, 2004).”
BackgroundMyostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 5×
“Consistent with this role, increased myostatin mRNA and protein expression appears to be a regular feature of human muscle wasting conditions such as AIDS (Gonzalez-Cadavid et al. 1998) and chronic muscle disuse (Reardon et al.”
BackgroundInfluentialSuppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505 · cited 2×
“5), and may have been in itself, or in combination with the upregulation of myostatin (also shown to inhibit muscle carbohydrate oxidation (McPherron & Lee, 2002), responsible for the reported induction of muscle insulin resistance typical of critical illness (Robinson & van Soeren, 2004).”
BackgroundGreenhaff, P. L., Karagounis, L. G., Peirce, N., Simpson, E. J., Hazell, M., Layfield, R., Wackerhage, H., Smith, K., Atherton, P., Selby, A., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90411.2008 · Cited by 495 · cited 2×
“…considered to be a prerequisite during inflammation-mediated muscle atrophy (Wray et al. 2003; Crossland et al. 2008), it would appear from human- and animal-based research that this is not always the case in non-inflammatory states (Constantin et al. 2007; Greenhaff et al. 2008; Vary et al. 2008).”
BackgroundSelf-citationWhat do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399 · cited 1×
“The role of the ubiquitin–proteasome system in muscle in critical illness Most, but not all, cellular proteins are degraded by the ATP-dependent ubiquitin–proteasome pathway (Jagoe & Goldberg, 2001).”
Background
Cited by
Acute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103
Exercise is the real polypill.
Fiuza-Luces, C., Garatachea, N., Berger, N. A., & Lucia, A. (2013) · Physiology · doi:10.1152/physiol.00019.2013 · Cited by 791
“Although myostatin increases might contribute to insulin resistance (184, 360), obesity (185), muscle wasting (63, 70, 97, 154), or agingsarcopenia (523), its loss/inhibition decreases adiposity (164, 303, 521, 530), induces browning of the white adipose tissue [through AMPK-peroxisome proliferator-activated receptor-…”
BackgroundExercise Attenuates the Major Hallmarks of Aging
Garatachea, N., Pareja-Galeano, H., Sanchis-Gomar, F., Santos-Lozano, A., Fiuza-Luces, C., Morán, M., Emanuele, E., Joyner, M. J., & Lucia, A. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1623 · Cited by 413
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
dos Santos, C., Hussain, S. N. A., Mathur, S., Picard, M., Herridge, M., Correa, J., Bain, A., Guo, Y., Advani, A., Advani, S. L., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2344oc · Cited by 282
Intensive Care Unit–acquired Weakness: Clinical Phenotypes and Molecular Mechanisms
Batt, J., dos Santos, C. C., Cameron, J. I., & Herridge, M. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0954so · Cited by 254
Ribosome biogenesis: Emerging evidence for a central role in the regulation of skeletal muscle mass
Chaillou, T., Kirby, T. J., & McCarthy, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24604 · Cited by 211
Brook, M. S., Wilkinson, D. J., Mitchell, W. K., Lund, J. N., Szewczyk, N. J., Greenhaff, P. L., Smith, K., & Atherton, P. J. (2015) · The FASEB Journal · doi:10.1096/fj.15-273755 · Cited by 206
“Our 6 wk RET protocol yielded increases in DXA-derived muscle mass over the 6 wk training period (46, 47) in T but not UT legs, agreeing with ultrasound measures.”
MethodSelf-citationDrummond, M. J., Addison, O., Brunker, L., Hopkins, P. N., McClain, D. A., LaStayo, P. C., & Marcus, R. L. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu004 · Cited by 161
Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
Haberecht-Müller, S., Krüger, E., & Fielitz, J. (2021) · Biomolecules · doi:10.3390/biom11091327 · Cited by 108
Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy
Huang, N., Kny, M., Riediger, F., Busch, K., Schmidt, S., Luft, F. C., Slevogt, H., & Fielitz, J. (2017) · Intensive Care Medicine Experimental · doi:10.1186/s40635-016-0115-0 · Cited by 95
Skeletal Muscle Molecular Responses to Resistance Training and Dietary Supplementation in COPD
Constantin, D., Menon, M. K., Houchen-Wolloff, L., Morgan, M. D., Singh, S. J., Greenhaff, P., & Steiner, M. C. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202764 · Cited by 88
Self-citationDrummond, M. J., Marcus, R. L., & LaStayo, P. C. (2012) · Journal of Aging Research · doi:10.1155/2012/486930 · Cited by 28
“[28] D.”
Nutritional Approaches to Treating Sarcopenia
Paddon‐Jones, D., & van Loon, L. (2012) · Sarcopenia · doi:10.1002/9781118338032.ch19 · Cited by 10
Metadata
- Authors
- Constantin, D., McCullough, J., Mahajan, R. P., & Greenhaff, P. L.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2011-07-28
- Volume
- 589
- Issue
- 15
- Pages
- 3883-3895
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W1739529336
- Cited by
- 100
- References
- 12
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.